Categories: Health

EssilorLuxottica: Second-Quarter and First-Half 2025 Results Conference Call Invitation

Second-Quarter and First-Half 2025 Results
Conference Call Invitation

Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer,
Mr PAUL DU SAILLANT, Deputy Chief Executive Officer,
Mr STEFANO GRASSI, Chief Financial Officer, and
Mr GIORGIO IANNELLA, Head of Investor Relations,
have the pleasure of inviting you to our Second-Quarter and First-Half 2025 Results Conference Call on:

Monday, July 28, 2025, at 6:30 pm CEST

Dial-in telephone access:

If you wish to dial into the conference call, please pre-register at the following link to receive the personal credentials (Dial-in numbers, Conference ID and User ID):

https://grid.trustwavetechnology.com/essilorluxottica/register.html

If you encounter any issue in the pre-registration phase you may contact ir@essilorluxottica.com, providing your name and surname and the name of your company.

Live webcast:

You can watch the presentation at the following link:

https://streamstudio.world-television.com/1217-2090-41873/en

The press release will be published at 6:00 pm CEST on the same day and the presentation slides will be made available prior to the call. Both can be found on https://www.essilorluxottica.com/investors.

GlobeNews Wire

Recent Posts

GENESIS MOTOR EUROPE APPOINTS PETER KRONSCHNABL AS NEW MANAGING DIRECTOR

Peter Kronschnabl joins Genesis Motor Europe as Managing DirectorAppointment supports Genesis’ strategic expansion into new…

2 hours ago

Silexion Therapeutics Announces Exercise of Warrants for $1.8 Million Gross Proceeds

Cayman Islands, July 31, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics”…

3 hours ago

MediciNova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million

July 31, 2025 19:30 ET  | Source: MediciNova, Inc. LA JOLLA, Calif., July 31, 2025…

3 hours ago

Pacific Health Care Organization, Inc. Reports its Second Quarter 2025 Financial Results

Irvine, July 31, 2025 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB:…

3 hours ago

Zenara Pharma Receives U.S. FDA Approval for First Generic of Sertraline Hydrochloride Capsules with 180-Day CGT Exclusivity

HYDERABAD, India, August 1, 2025 /PRNewswire/ -- Zenara Pharma Private Limited ("Zenara"), a Biophore company, today announced…

3 hours ago

ELLKAY President & CEO Joins White House Health IT Summit to Help Push Interoperability Forward

ELMWOOD PARK, N.J., August 1, 2025 /PRNewswire/ -- ELLKAY, a leading strategic data management partner in…

3 hours ago